Peviva

VLVbio AB is a Swedish biotechnology company with 7 employees, situated in Nacka, Stockholm.

VLVbio combines the innovative mindset and energy of a young company, founded in 2013, with the history and built-in expertise of a Product Line invented more than a decade ago at the Karolinska Institute in Stockholm, Sweden.

VLVbio are devoted to the invention and development of the original PEVIVA Keratin 18 Biomarkers M30® and M65® for the measurement of epithelial cell death in liver disease and oncology.

Our unique products are CE-marked and used globally by hospitals, academia and industry.

For more information, visit www.vlvbio.com.